Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consultant Urges Malaysian Biotechs, Industries To Talk To Each Other

This article was originally published in PharmAsia News

Executive Summary

A Malaysian consultant says biotechnology researchers and the industries that could benefit from their products are losing out on research grants because they are not communicating with each other. Biomillennium Consultancy's executive director said many biotech commercialization efforts have failed because of that lack of communication. Abdul Reezal said the government offers funds for research and development activities in universities, but the industrial sector has been largely inactive in investing in biotech. He urged a change in the mindset of those in industry and even on the part of some in government. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel